Bioequivalence of Boryung Torsemide Tablet to Torem Tablet (Torasemide 10 mg) by High Performance Liquid Chromatography/UV Detector |
Cho, Hea-Young
(Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Kang, Hyun-Ah (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Park, Chan-Ho (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Kim, Se-Mi (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Kim, Dong-Ho (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Park, Sun-Ae (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Kim, Kyung-Ran (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Hur, Hyeon (Department of Biology, Dongguk University) Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) |
1 | H. Knauf and E. Mutschler, Clinical pharmacokinetics and pharmacodynamics of torasemide, Clin. Pharmacokinet., 34(1), 1-24 (1998) DOI ScienceOn |
2 | H.P. Rang, M.M. Dale, J.M. Rtiter and P.K. Moore, Pharmacology, 5rd, ed., Churchill Livingstone, pp. 362 (2003) |
3 | The Martindale, 32rd, ed., Pharmaceutical Press, pp. 956 (1999) |
4 | G. Neugebauer, E. Besenfeledr, E.V. Mollendorff Pharmacokinetics and metabolism of torasemide in man, Arzneimittelforschung., 38(1A), 164-166 (1988) |
5 | M. Lesne, F. Clerckx-Braun, P. Duhoux and C. van Ypersele de Strihou, Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect, Int. J. Clin. Pharmacol. Ther. Toxicol., 20(8), 382-387 (1982) |
6 | M. B.Barroso, R.M. Alonso and R.M. Jimenez, Simultaneous determination of torasemide and its major metabbolite M5 in human urine by high-performance liquid chromatography-electrochemical detection, J. Chromatogr. Sci., 39(11), 491-496 (2001) DOI |
7 | Korea Food & Drug Administration Notification No. 2002-60, Standard Protocol of Bioequivalence Test (2002. 11. 22) |
8 | Guidance for Industry-Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Adaministration, Center for Drug Evaluation and Research, Center for Verternary Medicine, May 2001, http://www.fda.gov/cder/guidance/index.htm |
9 | Korea Food & Drug Administration, Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, Bioequivalence Division, Pharmacology Department, National Institute of Toxicology Department, 2003, http://www.kfda.go.kr/ |